Literature DB >> 6275439

A repeated test procedure to assess onset and duration of the cue properties of (-) delta 9-THC, (-) delta 8-THC-DMH and (+) delta 8-THC.

T U Järbe, M D Swedberg, R Mechoulam.   

Abstract

Rats were trained in a two-lever operant box in drug discrimination procedure to respond differentially to the effects induced by 3 mg/kg of (-) delta 9-tetrahydrocannabinol (delta 9-THC) and the drug vehicle. Tests with (-) delta 9-THC and the dimethyl-heptyl (DMH) homologue of (-) delta 8-THC indicated that (-) delta 8-THC-DMH was more potent but had a slower onset of action than (-) delta 9-THC. Two ways of testing the onset and duration of action were compared. In one procedure (separate tests) the time course of the drug action was established by testing each time interval on separate days with a new injection each test day, whereas in the other procedure (repeated tests) all intervals were evaluated after a single injection. The results were similar for both procedures. The median time intervals for the decay of the (-) delta 9-THC stimulus were 122 and 127 min for the separate and repeated tests procedures respectively. The median time intervals for the onset of action of the (-) delta 9-THC-like effects of (-) delta 8-THC-DMH were 65 and 62 min for the separate and repeated tests procedures respectively. The median time intervals for the decay of (-) delta 8-THC-DMH (0.30 and 0.56 mg/kg) was between 8 and 24h after injection. Furthermore, a stereoselective action is indicated, as (+) delta 8-THC (5.6 and 10 mg/kg) did not substitute for (-) delta 9-THC.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6275439     DOI: 10.1007/bf00432178

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  17 in total

1.  Structure-activity relationships in the tetrahydrocannabinol series. Modifications on the aromatic ring and it the side-chain.

Authors:  H Edery; Y Grunfeld; G Porath; Z Ben-Zvi; A Shani; R Mechoulam
Journal:  Arzneimittelforschung       Date:  1972-11

2.  Evaluation of phencyclidine analogs on the basis of their discriminative stimulus properties in the rat.

Authors:  H E Shannon
Journal:  J Pharmacol Exp Ther       Date:  1981-03       Impact factor: 4.030

3.  Delta9-THC as a discriminative cue in pigeons: effects of delta8-THC, CBD, and CBN.

Authors:  T U Järbe; B G Henriksson; G C Ohlin
Journal:  Arch Int Pharmacodyn Ther       Date:  1977-07

4.  Delta9-tetrahydrocannabinol and pentobarbital as discriminative cues in the Mongolian Gerbil (Meriones unguiculatus)

Authors:  T U Järbe; J O Johansson; B G Henriksson
Journal:  Pharmacol Biochem Behav       Date:  1975 May-Jun       Impact factor: 3.533

5.  Delta 9-Tetrahydrocannabinol, ethanol, and amphetamine as discriminative stimuli-generalization tests with other drugs.

Authors:  O F Bueno; E A Carlini; E Finkelfarb; J S Suzuki
Journal:  Psychopharmacologia       Date:  1976-04-15

6.  Discriminative response control produced with hashish, tetrahydrocannabinols (delta 8-THC and delta 9-THC), and other drugs.

Authors:  T U Järbe; B G Henriksson
Journal:  Psychopharmacologia       Date:  1974

7.  Amphetamine discrimination: onset of the stimulus.

Authors:  P B Silverman; B T Ho
Journal:  Pharmacol Biochem Behav       Date:  1980-02       Impact factor: 3.533

8.  Acute and subchronic influences of tetrahydrocannabinols on water and food intake, body weight, and temperature in rats.

Authors:  J O Johansson; T U Jarbe; B G Henriksson
Journal:  TIT J Life Sci       Date:  1975

9.  Reduction of hippocampal acetylcholine turnover in rats treated with (-)-delta 8-tetrahydrocannabinol and its 1',2'-dimethyl-heptyl homolog.

Authors:  A V Revuelta; D L Cheney; E Costa; N Lander; R Mechoulam
Journal:  Brain Res       Date:  1980-08-18       Impact factor: 3.252

10.  Characteristics of tetrahydrocannabinol (THC)-produced discrimination in rats.

Authors:  T U Järbe; J O Johansson; B G Henriksson
Journal:  Psychopharmacology (Berl)       Date:  1976-07-28       Impact factor: 4.530

View more
  11 in total

1.  Cannabinergic aminoalkylindoles, including AM678=JWH018 found in 'Spice', examined using drug (Δ(9)-tetrahydrocannabinol) discrimination for rats.

Authors:  Torbjörn U C Järbe; Hongfen Deng; Subramanian K Vadivel; Alexandros Makriyannis
Journal:  Behav Pharmacol       Date:  2011-09       Impact factor: 2.293

2.  Evaluation of fatty acid amides in the carrageenan-induced paw edema model.

Authors:  Laura E Wise; Roberta Cannavacciulo; Benjamin F Cravatt; Billy F Martin; Aron H Lichtman
Journal:  Neuropharmacology       Date:  2007-06-22       Impact factor: 5.250

Review 3.  "Herbal incense": designer drug blends as cannabimimetics and their assessment by drug discrimination and other in vivo bioassays.

Authors:  Torbjörn U C Järbe; Roger S Gifford
Journal:  Life Sci       Date:  2013-07-25       Impact factor: 5.037

4.  AM2389, a high-affinity, in vivo potent CB1-receptor-selective cannabinergic ligand as evidenced by drug discrimination in rats and hypothermia testing in mice.

Authors:  Torbjörn U C Järbe; Sherrica Tai; Brian J LeMay; Spyros P Nikas; Vidyanand G Shukla; Alexander Zvonok; Alexandros Makriyannis
Journal:  Psychopharmacology (Berl)       Date:  2011-10-12       Impact factor: 4.530

5.  Generalization of the discriminative stimulus properties of delta 9-THC to delta 9(11)-THC in rats.

Authors:  A Semjonow; M Binder
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

6.  A Cannabinoid CB1 Receptor-Positive Allosteric Modulator Reduces Neuropathic Pain in the Mouse with No Psychoactive Effects.

Authors:  Bogna M Ignatowska-Jankowska; Gemma L Baillie; Steven Kinsey; Molly Crowe; Sudeshna Ghosh; Robert A Owens; Imad M Damaj; Justin Poklis; Jenny L Wiley; Matteo Zanda; Chiara Zanato; Iain R Greig; Aron H Lichtman; Ruth A Ross
Journal:  Neuropsychopharmacology       Date:  2015-06-08       Impact factor: 7.853

7.  Discriminative stimulus functions of AM-1346, a CB1R selective anandamide analog in rats trained with Delta9-THC or (R)-methanandamide (AM-356).

Authors:  Torbjörn U C Järbe; Richard J Lamb; Qian Liu; Alexandros Makriyannis
Journal:  Psychopharmacology (Berl)       Date:  2006-09-05       Impact factor: 4.530

8.  Enantiomeric cannabinoids: stereospecificity of psychotropic activity.

Authors:  R Mechoulam; J J Feigenbaum; N Lander; M Segal; T U Järbe; A J Hiltunen; P Consroe
Journal:  Experientia       Date:  1988-09-15

9.  Discriminative stimulus functions in rats of AM1346, a high-affinity CB1R selective anandamide analog.

Authors:  Torbjörn U C Järbe; Chen Li; Qian Liu; Alexandros Makriyannis
Journal:  Psychopharmacology (Berl)       Date:  2008-06-03       Impact factor: 4.530

10.  Evidence for separate neuronal mechanisms for the discriminative stimulus and catalepsy induced by delta 9-THC in the rat.

Authors:  W R Prescott; L H Gold; B R Martin
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.